InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
T+90 hit rate
67%
T+90 mean return
+21.7%
Across 15 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Jacobs John C, Chief Executive Officer. Insider active across 2 companies, notably Harmony Biosciences Holdings, Inc.. Cumulatively, 16 filings have been published. Activity tracked since 13 September 2021. The latest transaction was filed on 1 March 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations16 total
83,334 shares0Common StockSEC:0001593968-25-000286:0
83,196 shares0Common StockSEC:0001593968-25-000137:0
83,197 sharesCommon StockSEC:0001209191-24-002239:0
40,000 shares@ US$8.2217.7% of flowCommon StockSEC:0001415889-22-008696:0
15,000 shares@ US$8.220.0068% mcap7.9% of flowCommon StockSEC:0001104659-22-071909:0
25,000 shares@ US$8.220.011% mcap13.2% of flowCommon StockSEC:0001104659-22-071014:0
15,000 shares@ US$8.220.0065% mcap7.5% of flowCommon StockSEC:0001104659-22-035613:0
25,000 shares@ US$8.220.011% mcap12.5% of flowCommon StockSEC:0001104659-22-034442:0
10,647 shares@ US$8.224.2% of flowCommon StockSEC:0001104659-22-001475
10,647 shares@ US$8.220.0044% mcap5.1% of flowCommon StockSEC:0001104659-22-001475:0
1,300 shares@ US$8.220.5% of flowCommon StockSEC:0001104659-21-154289
1,300 shares@ US$8.220.0005% mcap0.6% of flowCommon StockSEC:0001104659-21-154289:0
25,000 shares@ US$8.2210.0% of flowCommon StockSEC:0001104659-21-150129
25,000 shares@ US$8.220.010% mcap12.1% of flowCommon StockSEC:0001104659-21-150129:0
25,000 shares@ US$8.220.0100% mcap11.6% of flowCommon StockSEC:0000899243-21-035891:0
25,000 shares@ US$8.229.5% of flowCommon StockSEC:0000899243-21-035891
16 of 16 declarations
About Jacobs John C
John C. Jacobs is the President and CEO of Harmony Biosciences Holdings, Inc. He is responsible for the strategic and operational leadership of the company. With a strong background in the healthcare sector, John C. Jacobs plays a key role in developing innovative solutions for patients. He is committed to improving clinical outcomes and supporting the company's mission.
